JOINT FILING AGREEMENTJoint Filing Agreement • October 2nd, 2023 • Orbimed Advisors LLC • Pharmaceutical preparations
The undersigned hereby agree that Amendment No. 1 to Schedule 13D, dated September 29, 2023, with respect to the Class A ordinary shares of Apollomics Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
